These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1658763)

  • 1. A new low molecular weight heparan sulphate antagonizes kappa-carrageenan-induced thrombosis in rats.
    Gervasi GB; Bartoli C; Carpita G
    Pharmacol Res; 1991 Jul; 24(1):59-63. PubMed ID: 1658763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrageenin-induced thrombosis in rats and mice: a model for testing antithrombotic substances?
    Bekemeier H; Hirschelmann R; Giessler AJ
    Agents Actions; 1985 Jul; 16(5):446-51. PubMed ID: 4050621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evaluation method of the effect of nattokinase on carrageenan-induced tail thrombosis in a rat model.
    Kamiya S; Hagimori M; Ogasawara M; Arakawa M
    Acta Haematol; 2010; 124(4):218-24. PubMed ID: 21071931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin and phenprocoumon inhibit kappa-carrageenin induced thrombosis in rats.
    Hirschelmann R; Bekemeier H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):379-82. PubMed ID: 2428713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NaoXinTong Capsule Inhibits Carrageenan-Induced Thrombosis in Mice.
    Li Q; Chen Y; Zhao D; Wei Z; Zhang S; Chen Y; Wang Y; Qian K; Zhao B; Zhu Y; Gao X; Dong P; Li X; Duan Y; Han J; Yang X
    J Cardiovasc Pharmacol; 2018 Jul; 72(1):49-59. PubMed ID: 29738376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrageenin-induced thrombosis in the rat and mouse as a test model of substances influencing thrombosis.
    Bekemeier H; Hirschelmann R; Giessler AJ
    Biomed Biochim Acta; 1984; 43(8-9):S347-50. PubMed ID: 6517902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of flavonoids and lanthanides on kappa-carrageenin rat tail thrombosis.
    Bekemeier H; Gabor M; Hirschelmann R
    Exp Pathol; 1990; 40(1):61-3. PubMed ID: 2279536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some effects of prophylactic aspirins and heparins on concurrent arterial and venous thrombosis in the same animal.
    Iomhair MM; Lavelle SM
    Thromb Res; 1998 Dec; 92(5):229-32. PubMed ID: 9851814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of EPA (20:5 n-3 PUFA) on preventing venous thromboembolism: a rat tail thrombosis model experiment.
    Kuma H; Nagashima R; Hatae H; Tsuda T; Hamasaki N
    Thromb Res; 2013 Jan; 131(1):107-8. PubMed ID: 23040087
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving frequency of thrombosis by altering blood flow in the carrageenan-induced rat tail thrombosis model.
    Hagimori M; Kamiya S; Yamaguchi Y; Arakawa M
    Pharmacol Res; 2009 Oct; 60(4):320-3. PubMed ID: 19394423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans.
    Vogel GM; Meuleman DG; Bourgondiën FG; Hobbelen PM
    Thromb Res; 1989 Jun; 54(5):399-410. PubMed ID: 2549654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombosis (infarction) induced by kappa-carrageenin in rat tail: inhibition during adjuvant arthritis.
    Hirschelmann R; Bekemeier H
    Exp Pathol; 1987; 31(3):175-8. PubMed ID: 3609241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of propionyl carnitine in vascular disorders experimentally induced by endothelin (ET-1) serotonin and K-carrageenin.
    Bertelli A; Giovannini L; Galmozzi G; Bertelli AA
    Drugs Exp Clin Res; 1993; 19(1):7-11. PubMed ID: 8223141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of low molecular weight fucoidan and low molecular weight heparin in a rabbit model of arterial thrombosis.
    Durand E; Helley D; Al Haj Zen A; Dujols C; Bruneval P; Colliec-Jouault S; Fischer AM; Lafont A
    J Vasc Res; 2008; 45(6):529-37. PubMed ID: 18463418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic Activity of a Novel Diazepino[1,2-α] Benzimidazole Derivative on Arterial Thrombosis Model in Rats without Concomitant Pathology and in Rats with Experimental Myocardial Infarction.
    Spasov AA; Kucheryavenko AF; Sirotenko VS; Anisimova VA; Divaeva LN; Kuz'menko TA; Morkovnik AS
    Bull Exp Biol Med; 2019 Apr; 166(6):747-750. PubMed ID: 31020589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the best plasmatic activity which could be correlated with the antithrombotic effect of heparin and a low molecular weight heparin fragment?
    Doutremepuich C; Castrioto T; De Seze O; Pereira F; Doutremepuich F; Anne MC; Toulemonde F
    Thromb Res; 1987 Oct; 48(2):245-51. PubMed ID: 2827341
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative.
    Kaiser B; Hauptmann J; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):119-25. PubMed ID: 2459005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of new heparin-like compounds and other antithrombotic drugs and their interaction with vascular endothelial cells.
    Nader HB; Pinhal MA; Baú EC; Castro RA; Medeiros GF; Chavante SF; Leite EL; Trindade ES; Shinjo SK; Rocha HA; Tersariol IL; Mendes A; Dietrich CP
    Braz J Med Biol Res; 2001 Jun; 34(6):699-709. PubMed ID: 11378657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different antithrombotic mechanisms among glycosaminoglycans revealed with a new fucosylated chondroitin sulfate from an echinoderm.
    Pacheco RG; Vicente CP; Zancan P; Mourão PA
    Blood Coagul Fibrinolysis; 2000 Sep; 11(6):563-73. PubMed ID: 10997797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of (+/-)-2-(dimethylamino)-1-[[o-(m-methoxyphenethyl)phenoxy] methyl]ethyl hydrogen succinate on experimental models of peripheral obstructive disease.
    Hara H; Shimada H; Kitajima A; Tamao Y
    Arzneimittelforschung; 1991 Jun; 41(6):616-20. PubMed ID: 1930349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.